Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer

This study has been terminated.

(The study was terminated because Cell Genesys stopped all activities for GVAX.)

Sponsor:

Collaborators:

Cell Genesys

Medarex

Information provided by (Responsible Party):

A.J.M. van den Eertwegh, VU University Medical Center

ClinicalTrials.gov Identifier:

NCT01510288

First received: January 4, 2012

Last updated: January 10, 2012

Last verified: January 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	November 2011
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):